- Kewaunee Scientific press release (NASDAQ:KEQU): Q4 GAAP EPS of -$0.13.
- Revenue of $49.72M (+28.5% Y/Y).
- EBITDA for the quarter was $2.97M compared to a loss of $0.30M for the prior year period.
- The company's order backlog was $173.9M on April 30, 2022, increasing from $138.1M on January 31, 2022, and $114.5M on April 30, 2021.
Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M
Recommended For You
More Trending News
About KEQU Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
KEQU | - | - |
Kewaunee Scientific Corporation |